MIST Stock Price | Milestone Pharmaceuticals Inc P/E, Revenue, EPS, & Forecasts

Milestone Pharmaceuticals Inc • MIST

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Milestone Pharmaceuticals Inc

Ticker

MIST

Trading on

NASDAQ

ISIN

CA59935V1076

Industry

Biotechnology

Sector

Healthcare

CEO

Joseph G. Oliveto M.B.A.

Headquarters

1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6

Employees

Website

milestonepharma.com

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Metrics

BasicAdvanced

Market cap

$94.1M

P/E ratio

EPS

-$0.77

Dividend Yield

0.00%

Beta

0.92

Forward P/E ratio

EBIDTA

$-52M

Ex dividend date

Price & volume

Market cap

$94.1M

Average daily volume

0.7M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

77.32

Price to book

4.96

Earnings

EPS

-$0.77

EPS estimate (current quarter)

-$0.20

EPS estimate (next quarter)

-$0.28

EBITDA

$-52M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

0.92

52-week High

$2.75

52-week Low

$0.63

50-day moving average

$1.36

200-day moving average

$1.66

Short ratio

2.01

Short %

3.96%

Management effectiveness

ROE (TTM)

-307.27%

ROA (TTM)

-41.29%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

-100.00%

Share stats

Outstanding Shares

53.5M

Float

50.9M

Insiders %

4.71%

Institutions %

22.25%

Analyst Insights & forecasts

50% Buy

50% Hold

0% Sell

Based on information from 4 analysts.

Average price target

$3.33

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.14

-$0.19

26.32%

Q2 • 24Beat

-$0.14

-$0.16

10.88%

Q3 • 24Beat

-$0.19

-$0.15

-26.67%

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-12.4M

-∞%

Q4 • 24

$0M

$-20.8M

-∞%

Q1 • 25

NaN%

67.93%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$75.5M

$62.4M

82.59%

Q4 • 24

$61.9M

$68M

109.89%

Q1 • 25

-18.03%

9.07%

33.07%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-6.8M

$19.3M

$0M

$-6.9M

Q4 • 24

$-14M

$33.6M

$0.1M

$-14M

Q1 • 25

103.89%

73.70%

483.33%

103.23%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Milestone Pharmaceuticals Inc share?

Milestone Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Milestone Pharmaceuticals Inc have?

Milestone Pharmaceuticals Inc currently has 53.5M shares.

Does Milestone Pharmaceuticals Inc pay dividends?

No, Milestone Pharmaceuticals Inc doesn't pay dividends.

What is Milestone Pharmaceuticals Inc 52 week high?

Milestone Pharmaceuticals Inc 52 week high is $2.75.

What is Milestone Pharmaceuticals Inc 52 week low?

Milestone Pharmaceuticals Inc 52 week low is $0.63.

What is the 200-day moving average of Milestone Pharmaceuticals Inc?

Milestone Pharmaceuticals Inc 200-day moving average is $1.66.

Who is Milestone Pharmaceuticals Inc CEO?

The CEO of Milestone Pharmaceuticals Inc is Joseph G. Oliveto M.B.A..

How many employees Milestone Pharmaceuticals Inc has?

Milestone Pharmaceuticals Inc has 33 employees.

What is the market cap of Milestone Pharmaceuticals Inc?

The market cap of Milestone Pharmaceuticals Inc is $94.1M.

What is the P/E of Milestone Pharmaceuticals Inc?

The current P/E of Milestone Pharmaceuticals Inc is null.

What is the EPS of Milestone Pharmaceuticals Inc?

The EPS of Milestone Pharmaceuticals Inc is -$0.77.

What is the PEG Ratio of Milestone Pharmaceuticals Inc?

The PEG Ratio of Milestone Pharmaceuticals Inc is null.

What do analysts say about Milestone Pharmaceuticals Inc?

According to the analysts Milestone Pharmaceuticals Inc is considered a buy.